When the bacterial wall is readily breached and sensitivity reactions rapidly follow, these may be as damaging to the host as to the bacterium, as in caseating tuberculosis. When the invading bacterial wall for any reason is unaffected or only very slowly disintegrated, then a cellular granulomatous reaction is more likely to ensue as happens in sarcoidosis and leprosy. Tuberculin Insensitivity These responses may be inhibited by desensitizing with repeated subcutaneous doses of tuberculin or by some other functional modification of the antibody-forming mechanism such as interference with the normal activity of lymphocytes.
Although tuberculin densensitization abolishes the local (skin) responses to tuberculin, it does not impair immunity already acquired.
Failure to react to tuberculin occurs in those who have never met adequate amounts of mycobacteria to stimulate the response, or in infected people in whom the immunity mechanism has failed.
The vascular constituent of the tuberculin reaction but not the cellular infiltrate can be inhibited by direct suggestion under hypnosis (Black, Humphrey and Niven, I963) . Advanced active tuberculosis and other conditions in which suprarenal deficiency occurs may be accompanied by suppression of tuberculin sensitivity. It seems therefore that the antibody-forming mechanism can be stirred to activity, but the readiness of 'indigenous' lymphocytes to change to epithelioid cells and be diverted from normal activity makes them suspect as the weak link in the sarcoid's chain of immunological rectitude.
Converting the non-reacting sarcoid patient to tuberculin hypersensitivity appeared to have no beneficial effect on the sarcoidosis lesions except in one patient who developed bouts of erythema nodosum on both legs soon after BCG vaccination. During the healing of one crop of these red nodes a long-standing sarcoid skin lesion on one calf quickly disappeared and has not returned, although long-standing lung lesions have persisted.
One patient with widespread sarcoid nodules on the skin of his face and in both axillm and who reacted to protein and non-protein tuberculin, was desensitized with subcutaneous injections of PPD and lipopolysaccharide. After seven weeks of this he failed to react to 750 units of intradermal PPD and to 50 micrograms of lipopolysaccharide and the facial and axillary lesions rapidly paled and shrank away. In this case at all events, there is no doubt of the benefits of not reacting to tuberculin.
There is another hint of advantage to the sarcoid patient in a reduced tuberculin sensitivity. Women with sarcoidosis who become pregnant, tend to improve during the late months and early puerperium and to relapse afterwards. It is a common finding too, that tuberculin-reacting normal women develop much weaker tuberculin sensitivity during pregnancy.
Summary
The factors influencing tuberculin sensitivity and insensitivity are described. Their condition in sarcoidosis is discussed. It is suggested that the sarcoid patient who reacts to tuberculin might benefit from desensitizing and conversion to a non-reactor state. 
